Aspen API

About Aspen API

Aspen API is the cooperative force of Aspen Oss, The Netherlands and Fine Chemicals Corporation, South Africa . We are a driven and involved partner in the field of development, manufacturing and registration of complex and highly active pharmaceutical ingredients used for the production of finished dosage forms. With quality, compliance and collaboration at the core of our DNA, we continuously strive to improve and provide the ultimate solutions for our customers.

Our proactive quality and safety culture is firmly rooted in o...

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • NL
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from Aspen API (5)

  • Lanreotide

    Product Lanreotide

    Under development - samples available
  • Goserelin

    Product Goserelin

    Under development - samples are available
  • Relugolix

    Product Relugolix

    Under development - samples available
  • Segesterone acetate

    Product Segesterone acetate

    Under development - samples are available
  • Sugammadex

    Product Sugammadex

    Commercially available

Aspen API Resources (3)

  • Aspen API’s Green answer to peptide synthesis

    Sponsored Content Aspen API’s Green answer to peptide synthesis

    Our Green Continuous Liquid Phase Peptide Synthesis (GC-LPPS) combines the advantages of the classical solution-phase synthesis with the solid-phase approach. 
    5 Oct 2021
  • Aspen. Healthcare. We Care.

    Brochure Aspen. Healthcare. We Care.

    Aspen is a global specialty and branded pharmaceutical company committed to promoting access to medicines and improving the health of patients across the world through our high quality, affordable products. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability.
  • CPHI Trend Report - Sustainability in Pharma

    News CPHI Trend Report - Sustainability in Pharma

    While in the past, much of the discussion around sustainability in the pharmaceutical industry rightly focused on efforts to minimize the environmental impact of drug production, the needle has now shifted. There are signs that companies not only understand that it represents one of the world’s biggest challenges moving forward, but also that they are starting to incorporate sustainability practices into a much broader suite of operations.
    15 Jun 2021